Based on the results of the trial, vaccine may be licensed commercially in early 2021, says MGMCRI
from The Hindu - Home https://ift.tt/2WG8iAS
from SEO Tech Tips https://ift.tt/2WJg0u7
Unknown Based on the results of the trial, vaccine may be licensed commercially in early 2021, says MGMCRI
from The Hindu - Home https://ift.tt/2WG8iAS
https://ift.tt/eA8V8J December 25, 2020 at 05:32AM https://ift.tt/2yfVyVV
Friday, December 25, 2020
Third phase of Covaxin’s clinical trials begins at research institute
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment